Alimera Sciences Inc (ALIM)
3.45
+0.14
(+4.23%)
USD |
NASDAQ |
Apr 26, 16:00
3.45
0.00 (0.00%)
After-Hours: 20:00
Alimera Sciences Total Liabilities (Quarterly): 107.35M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 107.35M |
| September 30, 2023 | 105.35M |
| June 30, 2023 | 108.69M |
| March 31, 2023 | 67.16M |
| December 31, 2022 | 63.41M |
| September 30, 2022 | 61.51M |
| June 30, 2022 | 59.91M |
| March 31, 2022 | 58.53M |
| December 31, 2021 | 61.12M |
| September 30, 2021 | 58.56M |
| June 30, 2021 | 56.21M |
| March 31, 2021 | 57.55M |
| December 31, 2020 | 58.83M |
| September 30, 2020 | 56.71M |
| June 30, 2020 | 56.62M |
| March 31, 2020 | 54.40M |
| December 31, 2019 | 54.75M |
| September 30, 2019 | 53.20M |
| June 30, 2019 | 53.92M |
| March 31, 2019 | 51.66M |
| December 31, 2018 | 51.39M |
| September 30, 2018 | 48.23M |
| June 30, 2018 | 49.30M |
| March 31, 2018 | 47.57M |
| December 31, 2017 | 45.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 43.99M |
| June 30, 2017 | 44.17M |
| March 31, 2017 | 42.52M |
| December 31, 2016 | 44.64M |
| September 30, 2016 | 44.95M |
| June 30, 2016 | 46.96M |
| March 31, 2016 | 45.11M |
| December 31, 2015 | 44.16M |
| September 30, 2015 | 45.65M |
| June 30, 2015 | 54.00M |
| March 31, 2015 | 56.26M |
| December 31, 2014 | 59.14M |
| September 30, 2014 | 85.07M |
| June 30, 2014 | 35.00M |
| March 31, 2014 | 36.77M |
| December 31, 2013 | 24.54M |
| September 30, 2013 | 21.34M |
| June 30, 2013 | 27.88M |
| March 31, 2013 | 17.46M |
| December 31, 2012 | 13.38M |
| September 30, 2012 | 8.029M |
| June 30, 2012 | 6.884M |
| March 31, 2012 | 7.741M |
| December 31, 2011 | 9.72M |
| September 30, 2011 | 9.709M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
53.20M
Minimum
Sep 2019
108.69M
Maximum
Jun 2023
65.99M
Average
58.56M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 53.14B |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 153.52M |
| Shareholders Equity (Quarterly) | 46.17M |
| Debt to Equity Ratio | 1.397 |
| Current Ratio | 2.392 |
| Net Debt Paydown Yield | -1.83% |